Cleveland Clinic Cancer Center (Taussig) Outcomes
Renal Cell Cancer
Renal Cell Cancer
Five-Year Overall Survival of Patients With All Stages of Renal Cell Cancer (N = 4461)
2008-2018
ᵃNational comparison represents survival after diagnosis from Stat Facts: An interactive tool for access to Surveillance, Epidemiology, and End Results (SEER) cancer statistics. Surveillance Research Program, National Cancer Institute. https://seer.cancer.gov/statfacts/html/kidrp.html. Accessed July 7, 2019.
Five-Year Overall Survival of Patients With Renal Cell Cancer by Stageᵃ at Diagnosis (N = 4078)
2008-2018
| Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year |
|---|---|---|---|---|---|
| Stage I (N = 2401) | 2051 | 1746 | 1359 | 993 | 638 |
| Stage II (N = 173) | 150 | 124 | 87 | 60 | 48 |
| Stage III (N = 958) | 736 | 596 | 443 | 331 | 214 |
| Stage IV (N = 546) | 271 | 163 | 92 | 65 | 31 |
CC = Cleveland Clinic
ᵃ American Joint Committee on Cancer (AJCC) stage 0-V renal cell carcinoma
